Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 191

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Practical Management of Patients With Non–Small-Cell Lung Cancer Treated With Gefitinib

Shah, Neelam T., Kris, Mark G., Pao, William, Tyson, Leslie B., Pizzo, Barbara M., Heinemann, Murk-Hein, Ben-Porat, Leah, Sachs, Dana L., Heelan, Robert T., Miller, Vincent A.·2005·Journal of Clinical Oncology

Abstract

Purpose: The use of gefitinib, the first drug approved to inhibit the epidermal growth factor receptor tyrosine kinase, is indicated in patients with non–small-cell lung cancer with tumors progressive after chemotherapy. The unique mechanism of action of this agent leads to distinctive patterns of response and toxicity in persons with lung cancer. Many of the principles of management relevant to gefitinib are distinct from those with conventional cytotoxic drugs. To meet this need, we present practical guidelines on the use of gefitinib in patients with non–small-cell lung cancer. Methods: This article reviews gefitinib’s indications, dosing, response phenomena, and patterns of relapse in individuals with radiographic response. Results: We present our recommendations for the management of rash and diarrhea caused by this agent. Conclusion: This information can guide practitioners and help them inform their patients about what to expect when they receive gefitinib.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2005.04.057

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 191

Metadata

Authors
Shah, N. T., Kris, M. G., Pao, W., Tyson, L. B., Pizzo, B. M., Heinemann, M.-H., Ben-Porat, L., Sachs, D. L., Heelan, R. T., & Miller, V. A.
Venue
Journal of Clinical Oncology
Published
2005-01-01
Volume
23
Issue
1
Pages
165-174
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2118011560
Cited by
191
References
3
FWCI
21.08
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Practical Management of Patients With Non–Small-Cell Lung Cancer Treated With Gefitinib. https://app.cochat.ai/papers/10.1200/jco.2005.04.057
The paper
Shah, N. T., Kris, M. G., Pao, W., Tyson, L. B., Pizzo, B. M., Heinemann, M.-H., Ben-Porat, L., Sachs, D. L., Heelan, R. T., & Miller, V. A. (2005). Practical Management of Patients With Non–Small-Cell Lung Cancer Treated With Gefitinib. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2005.04.057

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.